RERAX
Price
$60.79
Change
-$0.26 (-0.43%)
Updated
Oct 17 closing price
Net Assets
137.72B
RIVIX
Price
$20.08
Change
-$0.05 (-0.25%)
Updated
Oct 17 closing price
Net Assets
2.64B
Interact to see
Advertisement

RERAX vs RIVIX

Header iconRERAX vs RIVIX Comparison
Open Charts RERAX vs RIVIXBanner chart's image
American Funds EUPAC R1
Price$60.79
Change-$0.26 (-0.43%)
VolumeN/A
Net Assets137.72B
American Funds International Vntg R-3
Price$20.08
Change-$0.05 (-0.25%)
VolumeN/A
Net Assets2.64B
RERAX vs RIVIX Comparison Chart in %
View a ticker or compare two or three
VS
RERAX vs. RIVIX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERAX is a Buy and RIVIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 138B vs. RIVIX (2.64B). RIVIX pays higher dividends than RERAX: RIVIX (0.86) vs RERAX (0.22). RERAX was incepted earlier than RIVIX: RERAX (23 years) vs RIVIX (6 years). RERAX (1.57) is less costly to investors than RIVIX (1.23). RERAX is a more actively managed with annual turnover of: 35.00 vs. RIVIX (20.00). RERAX (250) and RIVIX (250) have matching initial minimum investment requirements. RIVIX annual gain was more profitable for investors over the last year : 16.28 vs. RERAX (10.31). RIVIX return over 5 years is better than : 36.68 vs. RERAX (9.89).
RERAXRIVIXRERAX / RIVIX
Total Expense Ratio1.571.20131%
Annual Report Gross Expense Ratio1.571.23128%
Fund Existence23 years6 years-
Gain YTD21.05924.64485%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets138B2.64B5,229%
Annual Yield % from dividends0.220.8626%
Returns for 1 year10.3116.2863%
Returns for 3 years46.0762.9073%
Returns for 5 years9.8936.6827%
Returns for 10 years36.02N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GAP21.600.95
+4.60%
Gap Inc (The)
PCAPU10.55-0.09
-0.80%
Procap Acquisition Corp
BRNS1.33-0.02
-1.33%
Barinthus Biotherapeutics plc
JANX26.76-0.44
-1.62%
Janux Therapeutics
NVEC71.97-1.42
-1.93%
NVE Corp